Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Mark, please re-read what RG said about Quanta in his 6/16/08 SH letter: - D

True, we don't know what was in those contracts/licensing agreements. However, to assume that there wasn't at least a valient attempt by our legal team(s) to include the strongest language possible to assure that the intent was clear that the license only covered the parties to the agreement would be to assume that these patent attorneys, skilled in the art, were completely inept and unaware of the concept of patent exhaustion, though patent law in this regard is long-standing.

I actually believe that RG's language here was more about susceptability to dispute (i.e., focusing on 2nd teir users rather than chip manufacturers inherently limits susceptability to disputes with would-be future licensees).

Again the question comes to mind: Have licensees since the settlement with the J2.5 or, even more relevant, licensees since the LG/Quanta decision been users of chips manufactured solely by companies who have not acquired an MMP license?

I think you and I are on the same page - just furthering the discussion....

SGE

2
Jan 01, 2009 08:44AM

Jan 01, 2009 10:23AM

Jan 01, 2009 11:29AM

Jan 01, 2009 07:45PM
1
Jan 02, 2009 12:02AM

Jan 02, 2009 01:01AM
5
Jan 02, 2009 07:44AM
1
Jan 02, 2009 09:00AM
1
Jan 05, 2009 07:39AM
5
Jan 05, 2009 08:14AM

Jan 05, 2009 10:41AM

Jan 05, 2009 10:43AM

Jan 05, 2009 10:45AM
1
Jan 05, 2009 11:09AM
1
Jan 05, 2009 12:31PM
1
Jan 05, 2009 07:12PM
1
Jan 05, 2009 07:21PM
3
Jan 06, 2009 08:32AM
Share
New Message
Please login to post a reply